The Keys to Ibd 2010: Treatment, Diagnosis and Pathophysiology

Table of Contents

• Title Page / Table of Contents
• Preface
  Rogler, G. ; Sandborn, W.

• Impact of New Keys in Pathophysiology on IBD Treatment
• 386 Chemokines in Inflammatory Bowel Diseases
  Atreya, R. ; Neurath, M.F.
• Genes and Environment: How Will Our Concepts on the Pathophysiology of IBD Develop in the Future?
  Kaser, A. ; Zeissig, S. ; Blumberg, R.S.
• New Keys to Diagnostic Procedures: Laboratory Markers
• New Insights into IBD Epidemiology: Are There Any Lessons for Treatment?
  Bernstein, C.N.
• Smoking, Physical Activity, Nutrition and Lifestyle: Environmental Factors and Their Impact on IBD
  Cosnes, J.
• New Serologic Markers for Inflammatory Bowel Disease Diagnosis
  Dotan, I.
• Can Serologic Markers Help Determine Prognosis and Guide Therapy?
  Dubinsky, M.
• New Keys to Diagnostic Procedures: MRI, CT and Endoscopy
• CT Enterography: Is It the Current State-of-the-Art for Small Bowel Diagnostics?
  Bruining, D.H.
• MRI Enterography: The Future of Small Bowel Diagnostics?
  Feuerbach, S.
• Capsule and Balloon Endoscopy: When Are They Really Needed in Patients with Inflammatory Bowel Diseases?
  Herfarth, H.H. ; Long, M.D.
• Chromoendoscopy: What Is Its True Value for Ulcerative Colitis Surveillance?
  Kiesslich, R.
• General Treatment Considerations
• Supportive Therapy in IBD: What Additional Diagnoses and Conditions Must Be Treated?
  Swoger, J.M. ; Binion, D.G.
• What Is the Patient’s Perspective: How Important Are Patient-Reported Outcomes, Quality of Life and Disability?
  Peyrin-Biroulet, L.
• Evolving Concepts in IBD Therapy: What Should Be Studied in the Future?
  Schölmerich, J.
• New Keys to the Treatment of Ulcerative Colitis
• Does Treatment Schedule Matter? Once Daily versus Divided Doses of 5-ASAs
  Kane, S.
• New Keys to Maintenance Treatment in Ulcerative Colitis
  Higgins, P.D.R.
• Phosphatidylcholine (Lecithin) and the Mucus Layer: Evidence of Therapeutic Efficacy in Ulcerative Colitis?
  Stremmel, W. ; Hanemann, A. ; Ehehalt, R. ; Karner, M. ; Braun, A.
• The Role of Biologics in Ulcerative Colitis
  Hanauer, S.B.
• Timing and Indications for Colectomy in Chronic Ulcerative Colitis: Surgical Consideration
  Cima, R.R.
• New Keys to Immunosuppression
• Hepatotoxicity of Agents Used in the Management of Inflammatory Bowel Disease
  Khokhar, O.S. ; Lewis, J.H.
• Epstein-Barr Virus, Lymphoma Risk and the Potential Role of HIV Infection in IBD Patients Undergoing Immunosuppression
  Weinstock, D.M.
• Vaccines and Inflammatory Bowel Disease
  Kotton, C.N.
• State-of-the-Art: Immunosuppression and Biologic Therapy
  Sandborn, W.J.
• New Keys to CD Therapy
• What Options Do We Have for Induction Therapy for Crohn’s Disease?
  Siegel, C.A.
• How Rapidly Should Remission Be Achieved?
  Isaacs, K.L.
• Fistula Treatment: The Unresolved Challenge
  Vavricka, S.R. ; Rogler, G.
• Further Section
• Falk Symposium Series
• Author and Subject Index Vol. 28, No. 3, 2010